Abstract
Silver nanoparticles (AgNPs) are emerging as powerful tools in healthcare due to their unique properties, including antimicrobial activity, high surface area, and biocompatibility. They are widely used in medical applications such as wound healing, drug delivery, cancer therapy, and diagnostics, particularly for combating multidrug-resistant bacteria. AgNPs enhance the effectiveness of traditional antibiotics and show potential in synergistic therapies with other nanomaterials. However, challenges remain regarding their toxicity to human cells and the environment. The lack of standardized synthesis and application protocols complicates their regulatory approval and widespread use. To address these concerns, we should focus on engineering AgNPs to reduce toxicity, enhance specificity, and develop biodegradable systems to minimize environmental impact. However, AgNPs hold significant promise for advancing medical treatments, and current research is essential to ensure their safe and effective use in healthcare.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have